Ameritas Investment Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$188K Hold
20,932
0.01% 1329
2025
Q1
$157K Hold
20,932
0.01% 1421
2024
Q4
$157K Hold
20,932
0.01% 1475
2024
Q3
$159K Buy
20,932
+2,100
+11% +$16K 0.01% 1483
2024
Q2
$116K Hold
18,832
﹤0.01% 1625
2024
Q1
$95.7K Hold
18,832
﹤0.01% 1770
2023
Q4
$113K Hold
18,832
﹤0.01% 1652
2023
Q3
$133K Buy
18,832
+3,990
+27% +$28.2K 0.01% 1453
2023
Q2
$104K Hold
14,842
﹤0.01% 1573
2023
Q1
$124K Hold
14,842
﹤0.01% 1397
2022
Q4
$158K Buy
14,842
+902
+6% +$9.59K 0.01% 1298
2022
Q3
$175K Hold
13,940
0.01% 1122
2022
Q2
$147K Hold
13,940
0.01% 1245
2022
Q1
$227K Hold
13,940
0.01% 1109
2021
Q4
$193K Hold
13,940
0.01% 1255
2021
Q3
$200K Hold
13,940
0.01% 1199
2021
Q2
$220K Sell
13,940
-1,112
-7% -$17.5K 0.01% 1174
2021
Q1
$153K Hold
15,052
0.01% 1382
2020
Q4
$112K Hold
15,052
0.01% 1512
2020
Q3
$52K Buy
15,052
+2,322
+18% +$8.02K ﹤0.01% 1808
2020
Q2
$61K Hold
12,730
﹤0.01% 1708
2020
Q1
$25K Hold
12,730
﹤0.01% 2043
2019
Q4
$44K Buy
12,730
+4,433
+53% +$15.3K ﹤0.01% 1994
2019
Q3
$24K Hold
8,297
﹤0.01% 2285
2019
Q2
$31K Hold
8,297
﹤0.01% 2179
2019
Q1
$68K Hold
8,297
﹤0.01% 1705
2018
Q4
$67K Hold
8,297
﹤0.01% 1636
2018
Q3
$63K Hold
8,297
﹤0.01% 1856
2018
Q2
$48K Hold
8,297
﹤0.01% 2005
2018
Q1
$40K Buy
8,297
+1,600
+24% +$7.71K ﹤0.01% 2033
2017
Q4
$33K Hold
6,697
﹤0.01% 2161
2017
Q3
$34K Hold
6,697
﹤0.01% 2095
2017
Q2
$37K Buy
6,697
+1,100
+20% +$6.08K ﹤0.01% 2086
2017
Q1
$47K Buy
+5,597
New +$47K ﹤0.01% 1887